Imbalanced/JJ
expression/NN
of/IN
the/DT
glucocorticoid/NN
receptor/NN
isoforms/NNS
in/IN
cultured/VBN
lymphocytes/NNS
from/IN
a/DT
patient/NN
with/IN
systemic/JJ
glucocorticoid/NN
resistance/NN
and/CC
chronic/JJ
lymphocytic/JJ
leukemia/NN
./.

The/DT
human/JJ
glucocorticoid/NN
receptor/NN
(/(
GR/NN
)/)
is/VBZ
expressed/VBN
as/IN
two/CD
alternatively/RB
spliced/VBN
isoforms/NNS
,/,
GRalpha/NN
and/CC
GRbeta/NN
./.
=====
Whereas/IN
GRalpha/NN
is/VBZ
a/DT
hormone-activated/JJ
transcription/NN
factor/NN
,/,
GRbeta/NN
does/VBZ
not/RB
bind/VB
glucocorticoids/NNS
(/(
GCs/NNS
)/)
,/,
is/VBZ
transcriptionally/RB
inactive/JJ
,/,
and/CC
is/VBZ
a/DT
potential/JJ
inhibitor/NN
of/IN
activated/VBN
GRalpha/NN
./.
=====
Differential/JJ
expression/NN
of/IN
GR/NN
isoforms/NNS
may/MD
play/VB
a/DT
role/NN
in/IN
generalized/VBN
or/CC
tissue-specific/JJ
GC/NN
resistance/NN
./.
=====
GCs/NNS
induce/VBP
apoptosis/NN
in/IN
neoplastic/JJ
lymphoid/JJ
cells/NNS
;/:
and/CC
,/,
defective/JJ
apoptosis/NN
is/VBZ
implicated/VBN
in/IN
the/DT
genesis/NN
of/IN
chronic/JJ
lymphocytic/JJ
leukemia/NN
(/(
CLL/NN
)/)
./.
=====
We/PRP
studied/VBD
a/DT
patient/NN
with/IN
generalized/VBN
GC/NN
resistance/NN
and/CC
CLL/NN
./.
=====
GR/NN
number/NN
in/IN
the/DT
patient/NN
's/POS
transformed/VBN
lymphocytes/NNS
was/VBD
approximately/RB
one/CD
half/NN
that/DT
of/IN
control/JJ
cells/NNS
with/IN
a/DT
approximately/RB
10-fold/JJ
reduction/NN
in/IN
binding/NN
affinity/NN
for/IN
dexamethasone/NN
./.
=====
In/FW
vitro/FW
apoptosis/NN
induction/NN
in/IN
CLL/NN
cells/NNS
was/VBD
delayed/VBN
in/IN
response/NN
to/TO
GCs/NNS
,/,
but/CC
not/RB
to/TO
other/JJ
apoptosis/NN
inducers/NNS
./.
=====
Sequencing/NN
of/IN
the/DT
GR/NN
cDNA/NN
and/CC
gene/NN
including/VBG
the/DT
2.3-kb/JJ
coding/NN
region/NN
,/,
the/DT
intron/exon/NN
junctions/NNS
,/,
the/DT
known/JJ
5'-regulatory/JJ
region/NN
,/,
and/CC
approximately/RB
300/CD
bp/NN
of/IN
the/DT
3'-region/NN
revealed/VBD
no/DT
alterations/NNS
./.
=====
Western/NN
blot/NN
with/IN
an/DT
N-terminal/JJ
antibody/NN
showed/VBD
normal/JJ
levels/NNS
of/IN
immunoreactive/JJ
GR/NN
,/,
but/CC
quantitative/JJ
analysis/NN
with/IN
isoform-specific/JJ
C-terminal/JJ
antibodies/NNS
revealed/VBD
a/DT
markedly/RB
reduced/VBN
GRalpha/NN
expression/NN
,/,
and/CC
high/JJ
GRbeta/NN
expression/NN
./.
=====
These/DT
findings/NNS
indicate/VBP
that/IN
imbalanced/JJ
expression/NN
of/IN
the/DT
GR/NN
isoforms/NNS
may/MD
be/VB
a/DT
mechanism/NN
of/IN
GC/NN
resistance/NN
,/,
and/CC
may/MD
have/VB
implications/NNS
for/IN
tumorigenesis/NN
by/IN
enhancing/VBG
cell/NN
survival/NN
./.
=====
Copyright/NN
1999/CD
Academic/NNP
Press/NNP
./.